-
Something wrong with this record ?
Aqueous injection of quercetin: An approach for confirmation of its direct in vivo cardiovascular effects
EP. Porcu, M. Cossu, G. Rassu, P. Giunchedi, G. Cerri, J. Pourová, I. Najmanová, T. Migkos, V. Pilařová, L. Nováková, P. Mladěnka, E. Gavini,
Language English Country Netherlands
Document type Journal Article
- MeSH
- Antihypertensive Agents chemistry pharmacology therapeutic use MeSH
- Biological Availability MeSH
- Chemistry, Pharmaceutical MeSH
- Hypertension drug therapy MeSH
- Injections, Intravenous MeSH
- Blood Pressure drug effects MeSH
- Rats MeSH
- Humans MeSH
- Disease Models, Animal MeSH
- Rats, Inbred SHR MeSH
- Rats, Wistar MeSH
- Povidone chemistry MeSH
- Drug Compounding methods MeSH
- Quercetin chemistry pharmacology therapeutic use MeSH
- Solubility MeSH
- Particle Size MeSH
- Water chemistry MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Potential positive effects of flavonol quercetin on humans were suggested by many studies. However, it is not clear if these effects are mediated by quercetin or its metabolites. The in vivo confirmation of quercetin effects is largely hindered by its low water solubility and thus impossibility to test directly its impact. Therefore, a solid dispersion of quercetin with polyvinylpyrrolidone (PVP) was developed to prepare an injectable formulation of water-soluble quercetin. The optimized formulation provided a 20,000-fold increase in quercetin solubility. This formulation was tested on conventional and spontaneously hypertensive rats; it lowered their blood pressure in both short- and long-term basis. Pharmacokinetic data are also provided. This study reports for the first time an injectable water-soluble formulation of quercetin suitable for confirmation of its vascular effect in vivo.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033290
- 003
- CZ-PrNML
- 005
- 20181016115156.0
- 007
- ta
- 008
- 181008s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2018.02.036 $2 doi
- 035 __
- $a (PubMed)29474897
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Porcu, Elena Piera $u Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy. Electronic address: elena.piera1988@gmail.com.
- 245 10
- $a Aqueous injection of quercetin: An approach for confirmation of its direct in vivo cardiovascular effects / $c EP. Porcu, M. Cossu, G. Rassu, P. Giunchedi, G. Cerri, J. Pourová, I. Najmanová, T. Migkos, V. Pilařová, L. Nováková, P. Mladěnka, E. Gavini,
- 520 9_
- $a Potential positive effects of flavonol quercetin on humans were suggested by many studies. However, it is not clear if these effects are mediated by quercetin or its metabolites. The in vivo confirmation of quercetin effects is largely hindered by its low water solubility and thus impossibility to test directly its impact. Therefore, a solid dispersion of quercetin with polyvinylpyrrolidone (PVP) was developed to prepare an injectable formulation of water-soluble quercetin. The optimized formulation provided a 20,000-fold increase in quercetin solubility. This formulation was tested on conventional and spontaneously hypertensive rats; it lowered their blood pressure in both short- and long-term basis. Pharmacokinetic data are also provided. This study reports for the first time an injectable water-soluble formulation of quercetin suitable for confirmation of its vascular effect in vivo.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antihypertenziva $x chemie $x farmakologie $x terapeutické užití $7 D000959
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a krevní tlak $x účinky léků $7 D001794
- 650 _2
- $a farmaceutická chemie $7 D002626
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze $x farmakoterapie $7 D006973
- 650 _2
- $a injekce intravenózní $7 D007275
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a povidon $x chemie $7 D011205
- 650 _2
- $a quercetin $x chemie $x farmakologie $x terapeutické užití $7 D011794
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a voda $x chemie $7 D014867
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cossu, Massimo $u Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy. Electronic address: mcossu@uniss.it.
- 700 1_
- $a Rassu, Giovanna $u Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy. Electronic address: grassu@uniss.it.
- 700 1_
- $a Giunchedi, Paolo $u Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy. Electronic address: pgiunc@uniss.it.
- 700 1_
- $a Cerri, Guido $u Department of Architecture, Design and Urban Planning - GeoMaterials Lab, University of Sassari, Sassari, Italy. Electronic address: gcerri@uniss.it.
- 700 1_
- $a Pourová, Jana $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic. Electronic address: pourova@faf.cuni.cz.
- 700 1_
- $a Najmanová, Iveta $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic. Electronic address: najmanoi@faf.cuni.cz.
- 700 1_
- $a Migkos, Thomas $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic. Electronic address: migkost@faf.cuni.cz.
- 700 1_
- $a Pilařová, Veronika $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic. Electronic address: pilarovv@faf.cuni.cz.
- 700 1_
- $a Nováková, Lucie $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic. Electronic address: novakoval@faf.cuni.cz.
- 700 1_
- $a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic. Electronic address: mladenkap@faf.cuni.cz.
- 700 1_
- $a Gavini, Elisabetta $u Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy. Electronic address: eligav@uniss.it.
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 541, č. 1-2 (2018), s. 224-233
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29474897 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181016115653 $b ABA008
- 999 __
- $a ok $b bmc $g 1339418 $s 1030284
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 541 $c 1-2 $d 224-233 $e 20180221 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20181008